MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
about
Decoding the usefulness of non-coding RNAs as breast cancer markersCisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2.Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis.Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro.Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.Comparative aspects of MicroRNA Expression in Canine and Human Cancer.The mechanism study of miR-125b in occurrence and progression of multiple myeloma.Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.Functional miRNAs in breast cancer drug resistance.mTOR signaling-related MicroRNAs and Cancer involvement.High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids.MicroRNAs mediate therapeutic and preventive effects of natural agents in breast cancer
P2860
Q28069370-07D298B4-B99B-4925-9E8A-719BCD9F621DQ33713586-14B13571-819D-4DB8-89E3-06F4CF5793B4Q33798537-A5A4B9E2-96E2-4DA5-AB8A-FA6BEE90701BQ33838622-2E3B4CDD-A0A4-400F-A827-EF5B0F5B5291Q37610478-8883B1DF-586D-45AC-A21E-483706CCA3BDQ39630301-D5962C5F-9E03-4AD0-9CE8-45A307FC7503Q42365364-F02450C1-DD7D-4EA1-91EC-8839E8338A9FQ46065405-74AC56BA-19BF-4599-8E81-479CB2F5A238Q46304395-4865A0DA-A50C-4BAB-8366-930972F4D3FFQ47320868-AFE71853-F053-4F6A-B0D4-D83A6F3719BBQ48235043-E4E856CE-0B9F-4543-8F86-FBB491445280Q55000578-1B4BCE79-2E9A-440C-90FA-5DB799955434Q55069878-785A242A-2626-4F26-BFFE-9E930565A730Q55262767-E9A5BF9D-B4F4-4C29-A0DE-A65455ABABB6Q57118829-55DA552C-7AD9-4AAF-884D-84675B89695A
P2860
MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MicroRNA 100 sensitizes lumina ...... ent in part by targeting mTOR.
@en
type
label
MicroRNA 100 sensitizes lumina ...... ent in part by targeting mTOR.
@en
prefLabel
MicroRNA 100 sensitizes lumina ...... ent in part by targeting mTOR.
@en
P2093
P2860
P50
P356
P1433
P1476
MicroRNA 100 sensitizes lumina ...... ent in part by targeting mTOR.
@en
P2093
P2860
P304
P356
10.18632/ONCOTARGET.6790
P407
P577
2015-12-29T00:00:00Z